Publications by authors named "Jian-guang Lu"

Background: To examine the expression of cysteine-rich 61 (Cyr61/CCN1) protein in laryngeal squamous- cell carcinoma (LSCC) tissues, and its relationship with the tumor epithelial-mesenchymal transition (EMT), invasion, metastasis, and prognosis.

Materials And Methods: Immunohistochemistry was used to detect the expressions of Cyr61, Vimentin (Vim), and E-cadherin (E-cad) in 88 cases of LSCC tissues and 30 cases of tumor-adjacent normal tissues. Vim and E-cad were used as mesenchymal and epithelial markers, respectively, to determine the relationship between Cyr61 expression and the EMT of LSCC cells.

View Article and Find Full Text PDF

Cilengitide is a chemical synthesis cyclopeptide containing RGD sequence, which can be used as a small molecule antagonist targeted to integrin αν (ITGAV). The aim of present study was to investigate the effect on proliferation and cell apoptosis of the cilengitide in laryngeal cancer cells. In the study, we have treatmented the cultured cells of laryngeal cancer (Hep-2) with cilengitide.

View Article and Find Full Text PDF

miRNAs regulate gene expression and are key mediators of tumourigenesis. miR-129 has diverse effects in tumours, but its role in laryngeal squamous cell carcinoma (LSCC) remains unknown. This article focuses on the role of miR-129-5p in LSCC.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares the outcomes of transoral CO2 laser epiglottectomy and transcervical supraglottic laryngectomy in treating early-stage epiglottic cancers in 49 patients.
  • Researchers found key anatomical landmarks that aid in conducting CO2 laser surgery, including the upper edge of the thyroid cartilage.
  • Results showed lower hospitalization times and better survival rates for CO2 laser patients compared to those undergoing traditional open surgery, indicating its effectiveness with minimal complications.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the expression levels of KAI1/CD82 and MRP1/CD9 in laryngeal squamous cell carcinoma (LSCC) and their significance for patient outcomes.
  • It analyzed tissue samples from 100 LSCC patients and 30 non-cancerous controls, using techniques like Q-PCR and immunohistochemistry to compare expression levels and relate them to disease characteristics.
  • Results indicated that lower expression of these proteins in LSCC correlated with advanced disease features and poor survival, suggesting they could be important biomarkers for assessing LSCC progression and prognosis.
View Article and Find Full Text PDF

In the past several years, the αv integrin subfamily has been repeatedly found to be involved in tumor progression and angiogenesis. The aim of this study was to investigate the expression of the integrin αv subfamily in laryngeal squamous cell carcinoma (LSCC), and to correlate the expression rate with tumor biological behavior and angiogenesis of the LSCC. The integrin αv subfamily, including αv, β1, β3, β5, β6 and β8 subunits, was immunohistochemically found to be expressed in 64 patients with LSCC, and we analyzed the relationship between the expression rate and the clinicopathological stage of this cancer.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the relationship between abnormal E-cadherin expression and prognosis in patients with head and neck squamous cell carcinoma (HNSCC), using a systematic review and meta-analysis of existing literature.
  • Findings indicate that patients with aberrant E-cadherin expression have significantly poorer overall survival (OS), with a pooled hazard ratio of 2.533.
  • Subgroup analyses further confirm this trend across different populations and treatment types, suggesting that E-cadherin may be a reliable prognostic factor for HNSCC outcomes.
View Article and Find Full Text PDF

Purpose: Osteopontin (OPN) is a secreted phosphoprotein, which functions as a cell attachment protein and cytokine that signals through two cell adhesion molecules, integrin αvβ3 and CD44, to regulate cancer growth and metastasis. The aim of this study was to investigate the expression of OPN and integrin αv (ITGAV, main receptor of the OPN) in laryngeal and hypopharyngeal squamous cell carcinoma (LHSCC) and correlate the expression quantity with tumor biological behavior.

Methods: We have made a tissue microarray of LHSCC and detected the OPN and ITGAV expression by immunohistochemistry in the microarray.

View Article and Find Full Text PDF

The aim of this study was to evaluate the usefulness of osteopontin (OPN) expression level in plasma and tumor tissues of patients with laryngeal and hypopharyngeal squamous-cell carcinoma for predicting metastasis and survival of this tumor. The OPN expression in tumor tissues was detected by immunohistochemical staining in a tissue microarray of laryngeal and hypopharyngeal carcinomas, and the OPN level in plasma was measured by ELISA. The expression levels of OPN in plasma and tumor tissues were associated with clinicopathological features and survival of laryngeal and hypopharyngeal carcinomas.

View Article and Find Full Text PDF

Objective: The objective of the study was to explore the inhibitive role of cyclin D1 gene silence in laryngeal squamous cell carcinoma by lentivirus-mediated RNA interference.

Materials And Methods: Cd1-RNAi-Lentivirus and the control lentivirus (GFP-Lentivirus) were transfected into Hep-2 cells. Reverse transcriptase polymerase chain reaction was performed to explore the cyclin D1 expression level in Cd1-RNAi-Lentivirus-transfected Hep 2 cells.

View Article and Find Full Text PDF

The objective of this study was to investigate the role of alpha v-integrin subunit (ITGAV, CD51) in invasion and metastasis of the laryngeal and hypopharyngeal squamous cell carcinomas and to evaluate whether an antisense oligonucleotide sequence (ASONs) targeting ITGAV gene can result in proliferative inhibition and induce to apoptosis of laryngeal carcinoma cell lines (Hep-2). Firstly, a tissue microarray contained 75 primary carcinomas, 29 non-cancerous normal tissues and 20 metastatic lymph nodes was constructed and used to detect the expression of ITGAV by immunohistochemistry. The changes of ITGAV expression from each group were assessed and correlated to the clinical parameters of the patients.

View Article and Find Full Text PDF

Objective: To investigate the expression of integrin alpha-v subunit in laryngeal and hypopharyngeal squamous cell carcinomas (LHSCC) and to correlate the expression ratio with clinic and pathologic features of LHSCC, meanwhile, to investigate the relationship between the expression of integrin alpha-v subunit and tumor angiogenesis.

Methods: A tissue microarray of LHSCC was designed and made. Using this microarray, the expression of integrin alpha-v subunit in LHSCC was studied by immunohistochemistry, and the expression disparity in different clinic and pathologic staging of LHSCC was analyzed.

View Article and Find Full Text PDF

Objective: Data on traffic accident from year 2000 to 2002 were collected and testified. Epidemiological study was carried out to find the main risk factors of traffic accident.

Methods: The spatial distribution was conducted by means of Geographic Information System (GIS) and were marked on Shanghai digitalized map with different layers by different colors.

View Article and Find Full Text PDF

Objective: To study the laryngeal function reconstruction with sternohyvoid muscle after partial laryngectomy to treat T2 phase of glottis cancer.

Methods: 66 patients diagnosed to be at T2 phase of glottis cancer were treated by partial laryngectomy from 1992 to 1998. At the same time, they were rebuilt vocal cords with sternohyvoid muscle.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Jian-guang Lu"

  • - Jian-Guang Lu's research primarily investigates molecular mechanisms underlying laryngeal squamous cell carcinoma (LSCC), focusing on factors such as epithelial-mesenchymal transition, apoptosis, and the roles of specific proteins like Cyr61, integrins, and osteopontin in cancer progression and metastasis.
  • - Studies demonstrate that increased expression of key biomarkers, including KAI1/CD82, MRP1/CD9, and integrin subunits, correlates with poor prognosis, invasive behavior, and lymphatic metastasis in patients with laryngeal cancers.
  • - Lu's work emphasizes the therapeutic potential of targeting specific molecular pathways, such as the inhibition of integrin αv and the down-regulation of microRNAs and cyclins, proposing strategies for more effective treatment and management of LSCC.